Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases

Journal of Medicinal Chemistry
2017.0

Abstract

Bacterial histidine kinases (HKs) are quintessential regulatory enzymes found ubiquitously in bacteria. Apart from their regulatory roles, they are also involved in the production of virulence factors and conferring resistance to various antibiotics in pathogenic microbes. We have previously reported compounds that inhibit multiple HKs by targeting the conserved catalytic and ATP-binding (CA) domain. Herein, we conduct a detailed structure-activity relationship assessment of adenine-based inhibitors using biochemical and docking methods. These studies have resulted in several observations. First, interaction of an inhibitor's amine group with the conserved active-site Asp is essential for activity and likely dictates its orientation in the binding pocket. Second, a N-NH-N triad in the inhibitor scaffold is highly preferred for binding to conserved Gly:Asp:Asn residues. Lastly, hydrophobic electron-withdrawing groups at several positions in the adenine core enhance potency. The selectivity of these inhibitors was tested against heat shock protein 90 (HSP90), which possesses a similar ATP-binding fold. We found that groups that target the ATP-lid portion of the catalytic domain, such as a six-membered ring, confer selectivity for HKs.

Knowledge Graph

Similar Paper

Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases
Journal of Medicinal Chemistry 2017.0
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases
Bioorganic & Medicinal Chemistry Letters 2017.0
Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition
Bioorganic & Medicinal Chemistry 2018.0
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases
Journal of Medicinal Chemistry 2016.0
Rational Design and Evaluation of New Lead Compound Structures for Selective βARK1 Inhibitors
Journal of Medicinal Chemistry 2002.0
Structural Basis for Inhibition of Mycobacterial and Human Adenosine Kinase by 7-Substituted 7-(Het)aryl-7-deazaadenine Ribonucleosides
Journal of Medicinal Chemistry 2014.0
Crystal Structures of Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Isoquinolinesulfonyl Protein Kinase Inhibitors H7, H8, and H89
Journal of Biological Chemistry 1996.0
Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases
Journal of Medicinal Chemistry 1997.0
Adenine derived inhibitors of the molecular chaperone HSP90—SAR explained through multiple X-ray structures
Bioorganic & Medicinal Chemistry Letters 2004.0
Heterocyclic Bis-Cations as Starting Hits for Design of Inhibitors of the Bifunctional Enzyme Histidine-Containing Protein Kinase/Phosphatase from Bacillus subtilis
Journal of Medicinal Chemistry 2004.0